Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 15/20 | 0.78 |
| ▸ | FNTB | P49356 | 13/20 | 0.78 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.78 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.61 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopentenylpyrophosphate SCHEMBL16767444 | 1.00 | FNTA (0.78) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Farnesyl Diphosphate SCHEMBL6066352 | 1.00 | FNTA (0.78) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Farnesyl Diphosphate SCHEMBL6061708 | 0.99 | FNTA (0.80) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Geranyl Diphosphate SCHEMBL19971954 | 0.98 | FNTA (0.74) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Geranyl Diphosphate SCHEMBL16767264 | 0.98 | FNTA (0.74) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Isopentenylpyrophosphate SCHEMBL28016670 | 0.93 | FNTA (0.70) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Isopentenylpyrophosphate SCHEMBL28015989 | 0.93 | FNTA (0.70) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| Farnesyl Diphosphate SCHEMBL16987391 | 0.90 | FNTA (0.97) | FNTAFNTBPGGT1BBTN3A1 | |
| Geranyl Diphosphate SCHEMBL16767263 | 0.89 | FNTA (0.62) | FNTAFNTBPGGT1BBTN3A1GGPS1 | |
| SCHEMBL25272102 | 0.88 | FNTA (1.00) | FNTAFNTBPGGT1BBTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109890961-B | Geranylgeranyl pyrophosphate synthase | 帝斯曼知识产权资产管理有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20240067938-A1 | GERANYLGERANYL PYROPHOSPHATE SYNTHASES | DSM IP ASSETS B.V. (NL) | 2024-02-29 | — | — | US | disclosed |
| US-11781121-B2 | Geranylgeranyl pyrophosphate synthases | DSM IP ASSETS B.V. (NL) | 2023-10-10 | — | — | US | disclosed |
| US-20220228185-A1 | Recombinant Production of Steviol Glycosides | EVOLVA SA (CH) | 2022-07-21 | — | — | US | disclosed |
| US-20220090032-A1 | GERANYLGERANYL PYROPHOSPHATE SYNTHASES | DSM IP ASSETS B.V. (NL) | 2022-03-24 | — | — | US | disclosed |
| US-11225647-B2 | Geranylgeranyl pyrophosphate synthases | DSM IP ASSETS B.V. (NL) | 2022-01-18 | — | — | US | disclosed |
| US-20190284539-A1 | GERANYLGERANYL PYROPHOSPHATE SYNTHASES | DSM IP ASSETS B.V. (NL) | 2019-09-19 | — | — | US | disclosed |
| US-20180132515-A1 | GERANYLGERANYL PYROPHOSPHATE SYNTHASE | DSM IP ASSETS B.V. (NL) | 2018-05-17 | — | — | US | disclosed |
| US-9631215-B2 | Recombinant production of steviol glycosides | EVOLVA SA (CH) | 2017-04-25 | — | — | US | disclosed |
| US-9453244-B2 | Method for producing a monoalkene by enzymatic conversion of an alkyl monoester | GLOBAL BIOENERGIES (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20150159177-A1 | METHOD FOR PRODUCING A MONOALKENE BY ENZYMATIC CONVERSION OF AN ALKYL MONOESTER | GLOBAL BIOENERGIES (FR) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180132515-A1 | GERANYLGERANYL PYROPHOSPHATE SYNTHASE | GGPS1, FDPS, COASY | FNTA 7/4885FNTB 15/4885PGGT1B 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.